Seizures

 

A seizure is a sudden attack caused by problems with the electrical messages in your brain. Some chemotherapy may increase your risk of having a seizure. However, this risk is very small in most cases.

What is a seizure?

A seizure is a combination of disorganized body movements that result from overactivity of electrical impulses in your brain. Bodily function and movement is directed by the brain through electrical impulses carried by nerves. If there are too many of these impulses, disorganized movements will result, such as twitching, jerking, severe muscle contractions, and convulsions.

What causes seizures?

Seizures commonly occur in people who have epilepsy. Epilepsy is a disorder that is caused by anything that disrupts the normal pattern of neuron activity, including illness, brain damage, or abnormal brain development.

For people that do not have epilepsy, a variety of things can disrupt the normal pattern of neuron activity and cause a seizure, such as:

  • Trauma or injury to the head
  • Cancer of the brain or central nervous system
  • Low blood sodium levels or other electrolyte imbalances in the blood
  • Infection in the brain or central nervous system, such as meningitis
  • Stroke
  • Withdrawal from alcohol or drugs
  • Intoxication by alcohol or drugs

Chemotherapy itself does not cause seizures but may cause conditions that put a person at increased risk of seizure, such as dehydration from uncontrolled nausea and vomiting. Chemotherapy treatments that increase the risk of seizures include:

  • Administration of chemotherapy directly into the spinal cord (intrathecal or intravesical administration)
  • Some high doses of chemotherapy agents, such as busulfan for bone marrow transplantation

Your risk of seizure returns to normal once you are finished receiving this type of chemotherapy treatment.

This content was last modified on August 24, 2007 .
Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New VelcadeĀ®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health